Alzheimer's | Fortune

Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

Well
Boosting mental and physical activity can keep you sharp as you age
By
Alexa Mikhail
August 5, 2022
Well
Most women don’t know they have a higher risk of Alzheimer’s—and are too busy caring for others to take charge of their health
By
Alexa Mikhail
July 22, 2022
MPW
Vaxxinity CEO says the U.S. needs more vaccine options
By
Marco Quiroz-Gutierrez
October 13, 2021
International
Alzheimer’s villages could be the answer to the rising cases—and cost—of dementia
By
Sophie Mellor
October 8, 2021
Newsletters
The never ending Biogen Alzheimer’s drug saga delivers yet another twist
By
Sy Mukherjee
July 8, 2021
Health
Biogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug
By
Sy Mukherjee
July 8, 2021
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By
Sy Mukherjee
June 9, 2021
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By
Sy Mukherjee
June 7, 2021
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By
Sy Mukherjee
May 25, 2021
Newsletters
A week about Alzheimer’s drug development
By
Sy Mukherjee
March 18, 2021
Newsletters
Biogen is doubling down on Alzheimer’s with a massive gene therapy deal
By
Sy Mukherjee
February 28, 2020
Newsletters
The Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By
Sy Mukherjee
December 5, 2019
Newsletters
Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By
Sy Mukherjee
December 2, 2019
Newsletters
Bill Gates Commits $10 Million More for Alzheimer’s Research to ‘Part the Cloud’
By
Sy Mukherjee
November 5, 2019

1 - 14 of 53 results

1 - 14 of 53 results